Intellectual Property

U.S. Patent No. 7,598,080, awarded to Dr. Deirmengian has been assigned to CD Diagnostics, LLC. All files and information relating to this patent have been transferred to Saul Ewing in Philadelphia, PA. PCT application PCT/US12/61350 has been filed and carries priority date January 24, 2012. Continuation # US 12/549,657 was filed on August 28, 2009 and amended September 1, 2011. Continuations 13/231,647 and 13/231,665 were filed on September 13, 2011. We have also filed 5 new patents, which cover immunoassays for infection with joint replacements and native joints (61/590,234), gout (61/590,240), pseudogout (61/590,248), osteoarthritis (61/590,244), and rheumatoid arthritis (61/590,246). Additional patent filings, continuations, and continuations in part are being pursued.

Trademark applications have been submitted for both the name and logo associated with CD Diagnostics.